Corporate ActionJun 19, 2026, 04:31 PM
Ultragenyx Grants 44,409 RSUs to 15 New Non-Executive Officers
AI Summary
Ultragenyx Pharmaceutical Inc. reported the grant of 44,409 restricted stock units (RSUs) to 15 newly hired non-executive officers. These awards, approved by the compensation committee, were made under the Ultragenyx Employment Inducement Plan as an incentive for new employees. The RSUs will vest over four years, with 25% of the shares vesting on each anniversary of the June 16, 2026 grant date, contingent on continuous employment.
Key Highlights
- Ultragenyx granted 44,409 restricted stock units (RSUs).
- Awards were given to 15 newly hired non-executive officers.
- The grants were approved by the compensation committee of the board.
- Awards were made under the Ultragenyx Employment Inducement Plan.
- RSUs vest over four years, with 25% vesting annually.
- Grants serve as an inducement for new employees, per Nasdaq Listing Rule 5635(c)(4).
Price Impact
More from RARE